KKR Captain Shreyas Iyer Invests in Healthtech Startup Curelo

The startup plans to use the funding to expand, standardize unorganized labs, and triple its patient base in the next year.

Curelo, a Gurugram-based healthtech platform has secured a strategic investment, totaling INR 10 Cr from renowned Indian cricketer Shreyas Iyer and a clutch of investors.

The investment round witnessed participation from other prominent entities such as IIMA Ventures, industry stalwart Tarun Katial (Founder of Zee 5), and family offices in the United States.

Established in 2022 by laparoscopic surgeon Dr Arpit Jayswal, Curelo functions as an aggregator platform connecting patients with diagnostic labs, offering convenient at-home blood sample collection and timely reports.

Commenting on the investment and the importance of health and fitness in daily life, Iyer said,” I'm pleased to be a part of Curelo's journey. I firmly believe that health and fitness should constitute a key part in everyone's daily routine which resonates with Curelo's commitment to provide accessible and efficient services. They have an innovative and customer-friendly approach to diagnostics and healthcare, and I am excited to contribute to its

growth."

Per the startup, the platform includes a fleet of phlebotomists who ensure samples are collected within 60 minutes of booking. Curelo claimed it received a staggering 25-fold increase in revenue over the past year.

Sharing thoughts, Dr Arpit Jayswal, founder and CEO of Curelo, said, "We are delighted to welcome Shreyas Iyer as an investor in Curelo. His belief in our platform adds immense value as we continue to redefine the diagnostic market. This collaboration positions us as a trusted brand with accelerated growth and reinforces our commitment to serving the evolving needs of our users."

Hotting Up Healthtech Investment Scenario in India

The infusion of funds from this investment round is expected to play a pivotal role in Curelo's expansion plans. The startup intends to leverage the capital to expand its footprint further, standardize unorganized labs, and achieve exponential growth by acquiring 300% more patients in the coming year.

With a focus on enhancing accessibility and efficiency in healthcare services, Curelo aims to solidify its position as a leading player in the healthtech space. The platform seeks to revolutionize the healthcare industry with its innovative approach to diagnostics and patient care.

In a similar funding development, healthtech startup Ultrahuman recently secured a funding round totaling $35 million, comprising a blend of equity and debt investment. The startup's product suite includes a range of innovative wearables and devices designed to monitor key health metrics.

The capital infusion will empower Ultrahuman to ramp up its manufacturing capacity and intensify research efforts in the health tracking domain. Prominent venture capital firms led the financing round, including Blume Ventures, Steadview Capital, Nexus Venture Partners, Alpha Wave Incubation, and Zomato founder Deepinder Goyal.

Similarly, HiLabs, a prominent provider of AI-powered solutions designed to manage and unlock the potential of dirty data in healthcare, has bagged a whopping $39 million Series B financing round. The latest infusion of funds will support the continued enhancement of the technology, the recruitment of top-tier talent, and the expansion of its product teams.